Free Trial

Royalty Pharma (RPRX) SEC Filings & 10K Form

Royalty Pharma logo
$36.52 +0.06 (+0.16%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Royalty Pharma SEC Filings

DateFilerForm TypeView
08/13/2025
11:49 AM
Capital International Investors (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G
08/08/2025
3:58 PM
Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
4:00 PM
Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
3:52 PM
Royalty Pharma (Issuer)
Urist Marshall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
8:30 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2025
6:10 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025
10:56 AM
MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
07/31/2025
7:42 PM
Ho Carole (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
7:45 PM
Royalty Pharma (Issuer)
WEATHERMAN ELIZABETH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:23 PM
Royalty Pharma (Issuer)
WEATHERMAN ELIZABETH H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2025
7:40 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2025
4:06 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:05 PM
Legorreta Pablo G. (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13D
05/20/2025
3:49 PM
Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:51 PM
Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:52 PM
Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:22 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:41 PM
Engelbert Catherine M. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:04 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:06 PM
Coric Vlad (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:07 PM
DESOUZA ERROL B (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:08 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:09 PM
HODGSON DAVID C (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:11 PM
LOVE TED W (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:12 PM
Norden Gregory (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
9:39 AM
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
05/09/2025
4:07 PM
Royalty Pharma (Issuer)
Urist Marshall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:10 PM
Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:14 PM
Hite Christopher (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:15 PM
Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:18 PM
Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
8:14 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:31 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
5:19 PM
Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
Form SCHEDULE 13D/A
04/21/2025
4:43 PM
Coric Vlad (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:40 PM
Coric Vlad (Reporting)
Royalty Pharma (Issuer)
Form 3/A
04/21/2025
4:18 PM
Royalty Pharma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2025
8:15 AM
Royalty Pharma (Filer)
Form DEFA14A
04/11/2025
7:45 AM
Royalty Pharma (Filer)
Form DEFM14A
04/11/2025
7:50 AM
Royalty Pharma (Filer)
Form ARS
04/11/2025
7:53 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The stealth altcoin the financial world is underestimating (Ad)

This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening RIGHT NOW—this project is poised to see massive moves.... The smart money is already positioning.

Discover the protocol that's quietly replacing traditional finance.
04/10/2025
3:17 PM
Royalty Pharma (Filer)
Form DEFA14A
04/10/2025
3:06 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:45 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:46 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:25 PM
Royalty Pharma (Filer)
Form DEFA14A
02/21/2025
3:30 PM
Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
Form SCHEDULE 13D/A
02/13/2025
5:03 AM
Royalty Pharma (Filer)
Form PREM14A
02/12/2025
8:30 AM
FMR LLC (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
02/11/2025
6:38 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
4:12 PM
Royalty Pharma (Filer)
Form DEFA14A
01/16/2025
4:15 PM
Royalty Pharma (Filer)
Form DEFA14A
01/15/2025
4:04 PM
Royalty Pharma (Subject)
Form 425
01/13/2025
7:40 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:42 AM
Royalty Pharma (Filer)
Form DEFA14A
01/10/2025
4:21 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:26 PM
Royalty Pharma (Filer)
Form DEFA14A
01/10/2025
6:47 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:05 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
2:15 PM
MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
Form SC 13G/A
11/06/2024
8:24 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:35 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
4:07 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:08 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
7:39 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RPRX) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners